A 28-year-old man with a history of recurrent episodes of severe hypoglycemia (blood glucose 28–35 mg/dL) during prolonged fasting is evaluated. Fasting blood glucose is low, but serum glucose does not rise appropriately after 90 minutes of intravenous glucagon infusion (0.5 mg/min). Serum lactate and alanine are normal. Which investigation would best distinguish between hepatic gluconeogenic enzyme deficiency and glycogen synthase deficiency?

Explanation

## Differential Diagnosis: Gluconeogenic Enzyme Deficiency vs. Glycogen Synthase Deficiency ### Clinical Scenario Analysis The patient has: - Fasting hypoglycemia with poor glucagon response (suggests impaired gluconeogenesis) - Normal lactate and alanine (rules out severe lactic acidosis seen in G6Pase deficiency) - Hypoglycemia despite glucagon infusion (indicates gluconeogenic substrate availability but enzyme deficiency) ### Why Liver Biopsy with PEPCK and FBPase Assay is Diagnostic **Key Point:** The two main gluconeogenic enzyme deficiencies are: 1. **PEPCK deficiency** (rare) — impairs conversion of oxaloacetate → phosphoenolpyruvate 2. **FBPase deficiency** — impairs conversion of fructose-1,6-bisphosphate → fructose-6-phosphate Both present with fasting hypoglycemia and poor glucagon response, but: - **PEPCK or FBPase deficiency** → direct enzyme assay identifies the defect - **Glycogen synthase deficiency** → normal gluconeogenic enzyme activity; glycogen accumulates abnormally ### Mechanism of Glucagon Resistance ```mermaid flowchart TD A[Fasting State]:::outcome --> B[Glucagon released]:::action B --> C{Gluconeogenic enzyme intact?}:::decision C -->|Yes| D[Glucose produced normally]:::action C -->|No| E[Glucose production blocked]:::urgent E --> F[Hypoglycemia persists despite glucagon]:::outcome F --> G[Liver biopsy: enzyme assay]:::action G --> H{Which enzyme deficient?}:::decision H -->|PEPCK or FBPase| I[Gluconeogenic defect confirmed]:::outcome H -->|Both normal| J[Glycogen synthase deficiency likely]:::outcome ``` **High-Yield:** In glycogen synthase deficiency, gluconeogenic enzymes are normal, so glucagon *can* produce glucose from gluconeogenic substrates (lactate, alanine, glycerol), but glycogen cannot be synthesized properly. In PEPCK/FBPase deficiency, the gluconeogenic pathway itself is blocked. ### Why Liver Biopsy is Superior | Investigation | Distinguishes PEPCK/FBPase Deficiency? | Distinguishes Glycogen Synthase Deficiency? | Specificity | |---|---|---|---| | **Liver biopsy + enzyme assay** | Yes (direct measurement) | Yes (normal PEPCK/FBPase) | 100% | | Hepatic glycogen content (imaging) | No (may be normal in both) | Maybe (but non-specific) | Low | | Alanine/galactose loading | Indirect (poor response) | Indirect (better response) | Moderate | | Cortisol/GH levels | No (hormonal response, not enzyme) | No (hormonal response, not enzyme) | None | **Clinical Pearl:** Alanine loading *can* help clinically (PEPCK/FBPase deficiency → poor glucose rise; glycogen synthase deficiency → better glucose rise), but direct enzyme assay is the definitive diagnostic standard. ### Diagnostic Hierarchy 1. **Definitive:** Liver biopsy with PEPCK and FBPase activity measurement 2. **Supportive:** Alanine loading test (indirect) 3. **Genetic confirmation:** G6PC, PEPCK, or GYS2 gene sequencing [cite:Robbins 10e Ch 7; Harrison 21e Ch 364]